CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN) today announced results for its fourth quarter and full year ended December 31, 2007. Revenues for the fourth quarter were $336 million, resulting in full year sales of $1,282 million, an increase of 11 percent over the $1,151 million reported for 2006.
